The majority of the debt is Con Note, convertible at TP option or repayable. Revenues are strong from acquisitions and management are doing the right things here.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025